Maintenance Notice (3:00 AM November 1 - 8:30 AM November 1, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.199
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 4023-02-3 | Product Number: A2055
1-Amidinopyrazole Hydrochloride
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- Praxadine
- 1-Pyrazolecarboxamidine Hydrochloride
- Pyrazole-1-carboximidamide Hydrochloride
- 1-Carbamimidoylpyrazole Hydrochloride
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
Shipping Information
|
|---|---|---|---|---|---|
| 5G |
£23.00
|
5 | ≥40 |
|
|
| 25G |
£77.00
|
3 | ≥80 |
|
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | A2055 |
Purity / Analysis Method 
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__4H__6N__4·HCl = 146.58 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 4023-02-3 |
| Reaxys Registry Number | 5448758 |
| PubChem Substance ID | 87559963 |
| MDL Number | MFCD00210087 |
Specifications
| Appearance | White to Yellow to Orange powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 165.0 to 169.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 167 °C |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H302 : Harmful if swallowed. H315 : Causes skin irritation. H318 : Causes serious eye damage. H373 : May cause damage to organs through prolonged or repeated exposure. H317 : May cause an allergic skin reaction. H412 : Harmful to aquatic life with long lasting effects. |
| Precautionary Statements | P273 : Avoid release to the environment. P260 : Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P314 : Get medical advice/ attention if you feel unwell. P305 + P351 + P338 + P310 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor. |
Related Laws:
Transport Information:
| HS Number | 2933199090 |
Application
TCI Practical Example: Guanidinylation of Amine Using Praxadine
-
Used Chemicals
-
Procedure
-
A solution of 4-bromophenethylamine (200 mg, 1.00 mmol), DIEA (509 µL, 3.00 mmol) and praxadine (147 mg, 1.00 mmol) in DMF (1.7 mL) was stirred at ambient temperature for 2 days. The reaction mixture was concentrated and the residue was washed with dichloromethane/2-propanol (4:1 (vol/vol)). The guanidinylated compound 1 was obtained as a pale yellow solid (164 mg, 67% yield.) after filtration.
-
Experimenter’s Comments
-
The reaction mixture was monitored by LC/MS.
-
Analytical Data
-
Guanidinylated Compound 1
1H NMR (270 MHz, DMSO-d6); δ 7.57 (t, J = 6.3 Hz, 1H), 7.52 (d, J = 8.4 Hz, 2H), 7.25 (d, J = 8.4 Hz, 2H), 6.99 (brs, 3H), 3.35 (q, J = 6.3 Hz, 2H), 2.76 (t, J = 6.3 Hz, 2H).
-
Lead Reference
-
- Synthesis and pharmacological characterization of a new benzoxazole derivative as a potent 5-HT3 receptor agonist
Application
Guanidinylation
Typical Procedure:
1-Amidinopyrazole hydrochloride (1 g, 6.8 mmol) is added to a solution of 2-(benzoxazol-2-yl)ethylamine (1.1 g, 6.7 mmol) and diisopropylethylamine (4.75 mL, 27 mmol) in DMF (10 mL). The reaction mixture is stirred at room temperature under N2 for 24 h. Subsequently, diethylether (75 mL) is added, the upper layer is decanted and the remaining oil solidified by treatment with CH2Cl2. The solid is collected, washed with diethylether, CH2Cl2, and CHCl3 : i-PrOH (4 : 1) and dried to yield the product (0.86 g, Y. 52.6%).
1-Amidinopyrazole hydrochloride (1 g, 6.8 mmol) is added to a solution of 2-(benzoxazol-2-yl)ethylamine (1.1 g, 6.7 mmol) and diisopropylethylamine (4.75 mL, 27 mmol) in DMF (10 mL). The reaction mixture is stirred at room temperature under N2 for 24 h. Subsequently, diethylether (75 mL) is added, the upper layer is decanted and the remaining oil solidified by treatment with CH2Cl2. The solid is collected, washed with diethylether, CH2Cl2, and CHCl3 : i-PrOH (4 : 1) and dried to yield the product (0.86 g, Y. 52.6%).
References
- P. L. Lopez-Tudanca, L. Labeaga, A. Innerarity, L. Alonso-Cires, I. Tapia, R. Mosquera, A. Orjales, Bioorg. Med. Chem. 2003, 11, 2709.
- Y. Zhang, A. J. Kennan, Org. Lett. 2001, 3, 2341.
- A. Porcheddu, G. Giacomelli, A. Chighine, S. Masala, Org. Lett. 2004, 6, 4925.
PubMed Literature
Documents
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.